RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024July 08, 2024 - Eli Lilly acquires late-stage development Phase 2 small molecule company Morphic for US$3.2 Billion.
Lilly previously acquired a preclinical oral α4β7 program in its $2.4 billion takeover of Dice Therapeutics.
https://www.fiercebiotech.com/biotech/eli-lilly-inks-32b-morphic-buyout-snag-oral-rival-takedas-ibd-blockbuster